221 related articles for article (PubMed ID: 1319369)
1. Chemiluminescence assay of mucosal reactive oxygen metabolites in inflammatory bowel disease.
Simmonds NJ; Allen RE; Stevens TR; Van Someren RN; Blake DR; Rampton DS
Gastroenterology; 1992 Jul; 103(1):186-96. PubMed ID: 1319369
[TBL] [Abstract][Full Text] [Related]
2. Mucosal reactive oxygen metabolite production in duodenal ulcer disease.
Davies GR; Simmonds NJ; Stevens TR; Grandison A; Blake DR; Rampton DS
Gut; 1992 Nov; 33(11):1467-72. PubMed ID: 1452069
[TBL] [Abstract][Full Text] [Related]
3. Excessive production of reactive oxygen metabolites by inflamed colon: analysis by chemiluminescence probe.
Keshavarzian A; Sedghi S; Kanofsky J; List T; Robinson C; Ibrahim C; Winship D
Gastroenterology; 1992 Jul; 103(1):177-85. PubMed ID: 1612325
[TBL] [Abstract][Full Text] [Related]
4. Selective depletion of neutrophils by a monoclonal antibody, RP-3, suppresses dextran sulphate sodium-induced colitis in rats.
Natsui M; Kawasaki K; Takizawa H; Hayashi SI; Matsuda Y; Sugimura K; Seki K; Narisawa R; Sendo F; Asakura H
J Gastroenterol Hepatol; 1997 Dec; 12(12):801-8. PubMed ID: 9504889
[TBL] [Abstract][Full Text] [Related]
5. Chemiluminescence in inflammatory bowel disease patients: a parameter of inflammatory activity.
Oldenburg B; van Kats-Renaud H; Koningsberger JC; van Berge Henegouwen GP; van Asbeck BS
Clin Chim Acta; 2001 Aug; 310(2):151-6. PubMed ID: 11498080
[TBL] [Abstract][Full Text] [Related]
6. Increased production of luminol enhanced chemiluminescence by the inflamed colonic mucosa in patients with ulcerative colitis.
Sedghi S; Fields JZ; Klamut M; Urban G; Durkin M; Winship D; Fretland D; Olyaee M; Keshavarzian A
Gut; 1993 Sep; 34(9):1191-7. PubMed ID: 8406152
[TBL] [Abstract][Full Text] [Related]
7. Correlations between interleukin-8, and myeloperoxidase or luminol-dependent chemiluminescence in inflamed mucosa of ulcerative colitis.
Anezaki K; Asakura H; Honma T; Ishizuka K; Funakoshi K; Tsukada Y; Narisawa R
Intern Med; 1998 Mar; 37(3):253-8. PubMed ID: 9617859
[TBL] [Abstract][Full Text] [Related]
8. Imbalanced secondary mucosal antioxidant response in inflammatory bowel disease.
Kruidenier L; Kuiper I; Van Duijn W; Mieremet-Ooms MA; van Hogezand RA; Lamers CB; Verspaget HW
J Pathol; 2003 Sep; 201(1):17-27. PubMed ID: 12950013
[TBL] [Abstract][Full Text] [Related]
9. What do we measure with luminol-, lucigenin- and penicillin-amplified chemiluminescence? 1. Investigations with hydrogen peroxide and sodium hypochlorite.
Rost M; Karge E; Klinger W
J Biolumin Chemilumin; 1998; 13(6):355-63. PubMed ID: 9926363
[TBL] [Abstract][Full Text] [Related]
10. Intestinal oxidative damage in inflammatory bowel disease: semi-quantification, localization, and association with mucosal antioxidants.
Kruidenier L; Kuiper I; Lamers CB; Verspaget HW
J Pathol; 2003 Sep; 201(1):28-36. PubMed ID: 12950014
[TBL] [Abstract][Full Text] [Related]
11. Effects of iron and iron chelation in vitro on mucosal oxidant activity in ulcerative colitis.
Millar AD; Rampton DS; Blake DR
Aliment Pharmacol Ther; 2000 Sep; 14(9):1163-8. PubMed ID: 10971233
[TBL] [Abstract][Full Text] [Related]
12. Increased interleukin 8 expression in the colon mucosa of patients with inflammatory bowel disease.
Daig R; Andus T; Aschenbrenner E; Falk W; Schölmerich J; Gross V
Gut; 1996 Feb; 38(2):216-22. PubMed ID: 8801200
[TBL] [Abstract][Full Text] [Related]
13. What do we measure by a luminol-dependent chemiluminescence of phagocytes?
Vilim V; Wilhelm J
Free Radic Biol Med; 1989; 6(6):623-9. PubMed ID: 2546866
[TBL] [Abstract][Full Text] [Related]
14. Increased respiratory burst of leukocytes in inflammatory bowel diseases--the analysis of free radical generation by using chemiluminescence probe.
Suematsu M; Suzuki M; Kitahora T; Miura S; Suzuki K; Hibi T; Watanabe M; Nagata H; Asakura H; Tsuchiya M
J Clin Lab Immunol; 1987 Nov; 24(3):125-8. PubMed ID: 3430561
[TBL] [Abstract][Full Text] [Related]
15. In vitro determination of phagocyte activity by luminol- and lucigenin-amplified chemiluminescence.
Müller-Peddinghaus R
Int J Immunopharmacol; 1984; 6(5):455-66. PubMed ID: 6094369
[TBL] [Abstract][Full Text] [Related]
16. Luminol-enhanced chemiluminescence induced in peripheral blood-derived human phagocytes: obligatory requirement of myeloperoxidase exocytosis by monocytes.
Albrecht D; Jungi TW
J Leukoc Biol; 1993 Oct; 54(4):300-6. PubMed ID: 8409752
[TBL] [Abstract][Full Text] [Related]
17. Inflammatory bowel disease is associated with increased mucosal levels of bactericidal/permeability-increasing protein.
Monajemi H; Meenan J; Lamping R; Obradov DO; Radema SA; Trown PW; Tytgat GN; Van Deventer SJ
Gastroenterology; 1996 Mar; 110(3):733-9. PubMed ID: 8608882
[TBL] [Abstract][Full Text] [Related]
18. Abnormal mucosal glycoprotein synthesis in inflammatory bowel diseases is not related to cigarette smoking.
Ryder SD; Raouf AH; Parker N; Walker RJ; Rhodes JM
Digestion; 1995; 56(5):370-6. PubMed ID: 8549879
[TBL] [Abstract][Full Text] [Related]
19. Luminol-and lucigenin-amplified chemiluminescence with rat liver microsomes. Kinetics and influence of ascorbic acid, glutathione, dimethylsulfoxide, N-t-butyl-a-phenyl-nitrone, copper-ions and a copper complex, catalase, superoxide dismutase, hexobarbital and aniline.
Klinger W; Karge E; Kretzschmar M; Rost M; Schulze HP; Dargel R; Reinemann C; Rein H
Exp Toxicol Pathol; 1996 Jul; 48(5):447-60. PubMed ID: 8765690
[TBL] [Abstract][Full Text] [Related]
20. Reactive oxygen species and human spermatozoa: analysis of the cellular mechanisms involved in luminol- and lucigenin-dependent chemiluminescence.
Aitken RJ; Buckingham DW; West KM
J Cell Physiol; 1992 Jun; 151(3):466-77. PubMed ID: 1338331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
